AzTrials
AzTrials

Regional AnesthesiaNCT06756347

Comparative Analysis of Ultrasound-Guided Versus Landmark-Based Techniques for Regional Anesthesia in Egyptian Patients

A study testing Patients receiving landmark-based brachial plexus blocks, Landmark-Based Brachial Plexus Block and Bupivacaine in people with Regional Anesthesia, run by Assiut University.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

Regional anesthesia is a cornerstone in modern surgical practices due to its ability to provide effective pain management and reduce reliance on general anesthesia. Traditional landmark-based techniques, widely used due to their simplicity and cost-effectiveness, rely on surface anatomy and palpation to guide needle… Read more about this study

Who is it for?
Ages 18 to 65 years
Conditions the study is for
Regional Anesthesia
What is being tested?
Patients receiving landmark-based brachial plexus blocks, Landmark-Based Brachial Plexus Block and Bupivacaine
Could I receive a placebo?
No, everyone receives an active treatment
How many people
100 participants
Where
No sites listed yet
Study dates
1 Jan 2025to 1 Mar 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • ● Adult patients aged 18-65 years undergoing upper limb surgery requiring brachial plexus block.
  • Patients capable of providing informed consent

Who cannot join

  • ● Patients with contraindications to regional anesthesia (e.g., infection at the site, severe coagulopathy).
  • History of severe allergic reactions to local anesthetics.
  • Anatomical abnormalities affecting the brachial plexus block.
  • Obesity (BMI > 35) or other conditions that might confound results.

Trial locations and contacts

No sites are listed yet. Contact the study team or a site near you to ask about taking part.

Tarek Ashraf Ibrahim Abd Al-Hafiz, resident doctor contact

+201092002284

tarek.15235463@med.aun.edu.eg

About this study

Regional anesthesia is a cornerstone in modern surgical practices due to its ability to provide effective pain management and reduce reliance on general anesthesia. Traditional landmark-based techniques, widely used due to their simplicity and cost-effectiveness, rely on surface anatomy and palpation to guide needle placement. However, these techniques are associated with a higher risk of complications, including failed blocks and nerve injuries.

Ultrasound-guided techniques have emerged as a safer, more precise alternative, offering real-time visualization of anatomical structures. Studies suggest that ultrasound guidance improves the success rate, reduces procedural time, and minimizes complications. Despite global advancements in ultrasound-guided regional anesthesia, limited research addresses its efficacy and safety specifically in Egyptian patients, whose unique anatomical and physiological characteristics may influence outcomes.

This study seeks to fill this knowledge gap and provide evidence-based guidance tailored to this population, focusing on brachial plexus blocks.

Read the detailed description

Regional anesthesia is a cornerstone in modern surgical practices due to its ability to provide effective pain management and reduce reliance on general anesthesia. Traditional landmark-based techniques, widely used due to their simplicity and cost-effectiveness, rely on surface anatomy and palpation to guide needle placement. However, these techniques are associated with a higher risk of complications, including failed blocks and nerve injuries.

Ultrasound-guided techniques have emerged as a safer, more precise alternative, offering real-time visualization of anatomical structures. Studies suggest that ultrasound guidance improves the success rate, reduces procedural time, and minimizes complications. Despite global advancements in ultrasound-guided regional anesthesia, limited research addresses its efficacy and safety specifically in Egyptian patients, whose unique anatomical and physiological characteristics may influence outcomes.

Being tested
Patients receiving landmark-based brachial plexus blocks, Landmark-Based Brachial Plexus Block, Bupivacaine

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Patients receiving landmark-based brachial plexus blocksProcedure or surgery

    The operator will visualize anatomical structures in real time, identify the brachial plexus (supraclavicular approach), and guide the needle to the injection site under direct ultrasound visualization

  • Landmark-Based Brachial Plexus BlockProcedure or surgery

    The operator will identify anatomical landmarks (e.g., interscalene groove, supraclavicular fossa) using palpation and surface anatomy. The needle will be inserted based on these landmarks, with no direct visualization of internal structures.

  • BupivacaineDrug

    injected in both group as local anesthetic agent ( at a standardized concentration and volume) to ensure comparability.

Study groups in NCT06756347
Study groupRoleWhat they receive
Ultrasound-Guided GroupActive comparatorPatients receiving ultrasound-guided brachial plexus blocks .o Procedure performed using a high-frequency linear ultrasound probe.Real-time visualization of the brachial plexus for precise anesthetic delivery
Receives: Procedure: Patients receiving landmark-based brachial plexus blocks; Drug: Bupivacaine
Landmark-Based GroupActive comparatorPatients receiving landmark-based brachial plexus blocks.o Procedure performed based on anatomical landmarks and palpation, without imaging assistance
Receives: Procedure: Landmark-Based Brachial Plexus Block; Drug: Bupivacaine

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Success Rate

    Proportion of patients achieving adequate anesthesia (complete sensory block) within 30 minutes of administration.

    Measured: 30 minutes

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Jan 2025
  2. Study start1 Jan 2025 (estimated)
  3. Primary completion1 Jan 2026 (estimated)
  4. Study completion1 Mar 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Quadruple blind
Who is masked
Participant, Care provider, Investigator, Outcomes assessor
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06756347
Sponsor's protocol ID
US-Guided vs Land mark RA
Status last verified
Jan 2025
First submitted
24 Dec 2024
Last updated
3 Jan 2025
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Sivashanmugam T, Ray S, Ravishankar M, Jaya V, Selvam E, Karmakar MK. Randomized Comparison of Extrafascial Versus Subfascial Injection of Local Anesthetic During Ultrasound-Guided Supraclavicular Brachial Plexus Block. Reg Anesth Pain Med. 2015 Jul-Aug;40(4):337-43. doi: 10.1097/AAP.0000000000000264.

    PubMed 26066385

Questions about this trial

What is this clinical trial studying?

A study testing Patients receiving landmark-based brachial plexus blocks, Landmark-Based Brachial Plexus Block and Bupivacaine in people with Regional Anesthesia, run by Assiut University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 3 Jan 2025. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Tarek Ashraf Ibrahim Abd Al-Hafiz, resident doctor (+201092002284, tarek.15235463@med.aun.edu.eg), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Success Rate (time frame: 30 minutes). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06756347, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Jan 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in